NCT03374982

Brief Summary

Title: Effect of the DentalVibe injection system on pain during local anesthesia injections in children. Purpose: The purpose of this study is to compare self-reported pain scale measurements using the Wong-Baker FACES pain rating scale from an experimental group (local anesthesia injection with DentalVibe system) and a control group (traditional local anesthesia injection with DentalVibe system turned off) in children. Eligibility: Children age 5-11 years old who require local anesthesia for bilateral dental treatment at University of Nebraska Medical Center (UNMC) pediatric dental clinic. Children must understand and speak English. Interventions and evaluations: Each patient will have two separate restorative appointments where the DentalVibe will be used during local anesthetic injections. One appointment the DentalVibe will be turned on and one appointment the DentalVibe will be turned off. After each injection the child will be shown the Wong Baker FACES Pain Rating Scale and asked to pick a face associated with their level of hurt during the injection. Follow-up: All children will be followed up with any necessary recommended dental treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 15, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

February 19, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2019

Completed
4.6 years until next milestone

Results Posted

Study results publicly available

January 3, 2024

Completed
Last Updated

January 3, 2024

Status Verified

December 1, 2023

Enrollment Period

1 month

First QC Date

December 12, 2017

Results QC Date

July 15, 2023

Last Update Submit

December 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Self Reported Pain Rating Using Wong-Baker FACES Scale

    The scale includes pictures of facial expressions with correlating numerical scale of 0-10. 0 being no hurt and 10 being the worst hurt.

    Immediately after local anesthetic delivery

Study Arms (2)

DentalVibe turned On then turned Off

EXPERIMENTAL

DentalVibe will be turned on during local anesthetic injection at the first appointment. DentalVibe will be turned off during local anesthetic injection at the second appointment.

Device: DentalVibe

DentalVibe turned Off and then turned On

EXPERIMENTAL

DentalVibe will be turned off during local anesthetic injection at the first appointment. DentalVibe will be turned on during local anesthetic injection at the second appointment.

Device: DentalVibe

Interventions

The DentalVibe is a handheld device that delivers vibration to the tissue during local anesthetic administration.

DentalVibe turned Off and then turned OnDentalVibe turned On then turned Off

Eligibility Criteria

Age5 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children between the ages of 5-11 who require dental treatment that requires bilateral local anesthesia on the maxilla or mandible. Subjects must understand and speak English.

You may not qualify if:

  • No children with presence of medically or developmentally compromising conditions (autism, cerebral palsy, moderate/severe asthma); history of chronic disease (seizure disorder, cardiac disorder, hematological disease, endocrine disorder, liver disease, renal disease). Non-English speakers will be excluded. Subject who require oral sedation or general anesthesia for treatment due to behavior or medical history will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital & Medical Center Specialty Pediatric Center Dental Clinic

Omaha, Nebraska, 68114, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Zachary Houser
Organization
University of Nebraska Medical Center

Study Officials

  • Christopher H Johnson, DDS

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The person administering the FACES pain rating scale will be masked
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: This is a randomized cross-over clinical trial wherein the study subject serves as his or her own control.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 15, 2017

Study Start

February 19, 2018

Primary Completion

April 3, 2018

Study Completion

May 20, 2019

Last Updated

January 3, 2024

Results First Posted

January 3, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations